REBLOZYL® (luspatercept-aamt) is a prescription medicine used to treat anemia (low red blood cells) in adults with myelodysplastic syndromes with ring sideroblasts (MDS-RS) or myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) who need regular RBC transfusions and have not responded well to or cannot receive an erythropoiesis stimulating agent (ESA).
REBLOZYL is not for use as a substitute for RBC transfusions in people who need immediate treatment for anemia.
It is not known if REBLOZYL is safe or effective in children under 18 years of age.
This website is best viewed using the horizontal display on your tablet device.
This website is best viewed using the vertical display on your mobile device.
Be sure to talk to your healthcare team about what you should write down and track between REBLOZYL injections. This may include:
It’s likely you will have questions about REBLOZYL during your treatment journey. There is a lot of new information to learn and a lot of things to keep track of. It’s important to talk with your healthcare team—they are here to help you along your journey. You can download the Doctor Discussion Guide to help with those conversations.